Intermediate Capital Group -- Video Interview with Managing Director
October 11, 2005 02:15 ET
|
Cantos
LONDON, Oct. 11, 2005 (PRIMEZONE) -- Intermediate Capital Group (ICG) -- interim results. Indepth interview available now on www.cantos.com with Tom Attwood, Managing Director (LSE:ICP).
-...
INTERMEDIATE CAPITAL GROUP - video interview with Managing Director
October 11, 2005 02:07 ET
|
Intermediate Capital Group plc
Indepth interview available now on www.cantos.com with Tom Attwood, Managing Director (LSE:ICP)
- Financials and IFRS
- Market trends
- Competitive position
- Deal flow
- Fund management...
Rodamco Europe signs agreement to acquire shopping center in Helsinki, Finland for € 135 million.
October 11, 2005 02:00 ET
|
Unibail-Rodamco-Westfield SE
The Jumbo shopping center consists of an existing part (GLA approx. 56,000 m² completed in 1999) and an extension (GLA approx. 29,000 m²) to be opened on October 26, 2005. The latter will be delivered...
Avanza: Interim Report, 1st January -- 30th September 2005
October 11, 2005 01:41 ET
|
Avanza
STOCKHOLM, Sweden, Oct. 11, 2005 (PRIMEZONE) -- Avanza:
-- Operating income increased by SEK 29.5% (50.5%) to SEK 201.5
million (SEK 155.6 m).
-- The profit after tax was SEK 73.5...
Basilea's First-in-Class Antibiotic Ceftobiprole Aims at Broader Indication Including Diabetic Foot Infections
October 11, 2005 01:27 ET
|
Basilea Pharmaceutica Ltd
BASEL, Switzerland, Oct. 11, 2005 (PRIMEZONE) -- Basilea Pharmaceutica Ltd. (SWX:BSLN) today announced the start of an additional pivotal Phase III trial with its development partner Johnson &...
Basilea's first-in-class antibiotic ceftobiprole aims at broader indication including diabetic foot infections
October 11, 2005 01:15 ET
|
Basilea Pharmaceutica AG
Basel, Switzerland, October 11, 2005
Basilea Pharmaceutica Ltd. (SWX:BSLN) today announced the start of an additional pivotal Phase III trial with its development partner Johnson &...
Basileas neuartiges Antibiotikum Ceftobiprol zielt auf eine noch breitere Anwendung einschliesslich Fussinfektionen bei Diabetikern
October 11, 2005 01:15 ET
|
Basilea Pharmaceutica AG
Basel, 11. Oktober 2005
Basileas neuartiges Antibiotikum Ceftobiprol zielt auf eine noch breitere Anwendung einschliesslich Fussinfektionen bei Diabetikern
Die Basilea Pharmaceutica...
Basileas neuartiges Antibiotikum Ceftobiprol zielt auf eine noch breitere Anwendung einschliesslich Fussinfektionen bei Diabetikern
October 11, 2005 01:14 ET
|
Basilea Pharmaceutica AG
Basel, 11. Oktober 2005
Basileas neuartiges Antibiotikum Ceftobiprol zielt auf eine noch breitere Anwendung einschliesslich Fussinfektionen bei Diabetikern
Die Basilea Pharmaceutica...
Nokia Introduces Carbide.c++, New Family of Development Tools for Symbian OS
October 11, 2005 01:04 ET
|
Nokia Oyj
Carbide.c++ delivers developer productivity across entire Symbian ecosystem, leverages open-source Eclipse framework to encourage innovation and improve efficiency
London, UK/Espoo, Finland...
Nokia Expands Support for Advanced Smartphone Application Development Companies
October 11, 2005 01:01 ET
|
Nokia Oyj
New Forum Nokia PRO Symbian Zone Provides Exclusive Access to Technical Resources
London, UK/Espoo, Finland - Nokia (NYSE: NOK), the global leader in mobility, today launched an early...
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
- July 26, 2024 16:30 ET Arhaus Unveils Showroom in Palo Alto, California